Key result
Non-adherence to at least one secondary prevention medicine was reported by 43.5% of CAD patients, with modifiable factors including aspirin prescription (OR 2.22) and specific concerns (OR 1.12).
Why the study?
Non-adherence to secondary prevention medicines among patients with coronary artery disease remains a clinical challenge, motivating the identification of modifiable barriers that can be addressed in practice.
What are the modifiable barriers to adherence to secondary prevention medicines in patients with coronary artery disease?
Cross-Sectional (n=503)
No
What are the modifiable barriers to adherence to secondary prevention medicines in patients with coronary artery disease?
Non-adherence to secondary prevention medicines in CAD patients is common (43.5%) and driven by modifiable factors such as forgetfulness, concerns about harm, and practical issues like repeat prescriptions.
No takes yet. Share an insight, caveat, or question.
Non-adherence to secondary prevention medicines remains common in CAD; supports targeting modifiable barriers but leaves open causal effects on outcomes.
Khatib et al. (2019) conducted a cross-sectional in Coronary artery disease (n=503). Secondary prevention medicines was evaluated on Non-adherence to at least one secondary prevention medicine. Non-adherence to at least one secondary prevention medicine was reported by 43.5% of CAD patients, with modifiable factors including aspirin prescription (OR 2.22) and specific concerns (OR 1.12).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: